Collectively, our data showed that the mRNA and protein levels of MMP9 were enhanced in ccRCC, and the increased level of MMP9 may be due to the activation of the MAPK/ERK signaling pathway. This evidence concerns the gene MAPK1 and nonpapillary renal cell carcinoma.